The ESTIV Members Area
Become member of ESTIV
European Society of Toxicology In Vitro > News > ESTIV and EUSAAT signed a Memorandum of Understanding
1 October 2022

ESTIV and EUSAAT signed a Memorandum of Understanding

The European Society of Toxicology in Vitro (ESTIV) and the European Society for Alternatives to Animal Testing EUSAAT signed a Memorandum of Understanding at the EUSAAT 2022 congress in Linz. The MoU aims to intensify collaboration between the two EU societies with a focus on the implementation of 3Rs and New Approach Methodologies (NAMs) into modern science, research and regulations. More information on the collaboration between the two societies will be announced at the ESTIV 2022 Congress in Barcelona-Sitges.

Related content

2026 ESTIV Applied Training Course – the early-bird registration deadline is approaching!

The deadline for the reduced registration fee is approaching fast — 31 July is the last day! 🚨

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

Silver Sponsor

React4Life

Corporate Members
Mattek in Vitro Life Science Laboratories

Communication partners

Memorandum of Understanding